#CancerDiagnostics
LightNews LightNews
myesmo.bsky.social
🤖 AI is accelerating #CancerDiagnostics - improving both speed and accuracy.
Learn more in the session “AI-based biomarkers for precision oncology” at #ESMOAI25 in Berlin.
👉 www.esmo.org/meeting-cale...

#DigitalOncology #PrecisionOncology #HealthAI
November 7, 2025 at 8:09 AM
stratechdx.bsky.social
Early detection of liver cancer is challenging, that’s why IHC matters. Bio SB creates reliable #antibodies that help pathologists detect cancer sooner and more accurately

Find out more here: 🔗www.stratech.co.uk/b...

#pathology #IHC #diagnostics #CancerDiagnostics #pathologists #BIOSB
October 28, 2025 at 8:00 AM
cypathlung.bsky.social
AI is revolutionizing cancer detection. The USPTO plans to grant bioAffinity Technologies a patent for our AI-powered flow cytometry platform that detects lung cancer with precision and consistency. Learn more: bit.ly/42N8CAq
#CyPathLung #cancerdiagnostics #patent #AI
bit.ly
October 17, 2025 at 3:24 PM
myesmo.bsky.social
Natasha Leighl, recipient of the 2025 ESMO Women for Oncology Award, will present her Award lecture at the #ESMO25 Opening Session. She will discuss key contributions to #LungCancer research & the role of liquid biopsy in #CancerDiagnostics.

📅 Opening Session https://ow.ly/BwMO50XavIS
October 15, 2025 at 3:01 PM
laosaal.bsky.social
✅ Interested in the latest in #cancer #liquidbiopsy, circulating tumor DNA ( #ctDNA), and #MRD testing? 🧪

I'll be a #panelist on a virtual #roundtable on October 22nd.

Signup below. Hosted by @genomeweb.bsky.social

event.on24.com/wcc/r/508470...

#oncology #bcsm #cancerdiagnostics #dPCR
Virtual Roundtable: Evolving Technologies for Molecular Residual Disease Testing in Solid Tumors, Perspectives on Platforms and Clinical Utility
Wednesday, October 22, 2025 at 12:00 PM Eastern Daylight Time.
event.on24.com
October 13, 2025 at 1:31 PM
newswise.bsky.social
In Extensive Sequencing Study, Scientists Find Few Links Between Cancer and Microbiome
www.newswise.com/articles/in-...
#Microbiome #cancer #cancerawareness #genomicsequencing #CancerDiagnostics
In Extensive Sequencing Study, Scientists Find Few Links Between Cancer and Microbiome | Newswise
About a dozen studies in the past five years have made claims linking nearly every type of human cancer with the presence of microbiomes, “communities” of bacteria, viruses and fungi that live in or o...
www.newswise.com
October 7, 2025 at 9:38 AM
shubham83.bsky.social
The MRD Testing Market enhances cancer detection and therapy monitoring. 🧬🔬 www.marketresearchfuture.com/reports/mini... #CancerDiagnostics #MRD #Oncology
Minimal Residual Disease Testing Market Report, 2032
Minimal Residual Disease Testing Market is projected to register a CAGR of 11.36% to reach USD 7.09 billion by 2032, Minimal Residual Disease Testing Industry analysis by Technology, Application and E...
www.marketresearchfuture.com
October 7, 2025 at 7:31 AM
yuvip.bsky.social
Liquid Biopsy Market to reach $24.74M by 2034, at a 10.52% CAGR. Driving early cancer detection & precision medicine. 🔬 #LiquidBiopsy #CancerDiagnostics #Healthcare

Read More: www.globalhealthcaretoday.com/article/7757...
Liquid Biopsy Market Poised to Growth USD 24.74 Million by 2034 with Thriving CAGR of 10.52% | Global Healthcare Today
Global Healthcare Today is an online news publication focusing on health & wellness: The latest news on healthcare and wellness
www.globalhealthcaretoday.com
October 3, 2025 at 6:01 AM
d-and-d-world.bsky.social
Resitu Medical's breast biopsy device, RESL09, receives US FDA 510(k) clearance. This minimally invasive tool for large tissue samples is a breakthrough for cancer diagnostics.

#News #BreastBiopsy #FDA #MedTech #Innovation #CancerDiagnostics #Diagnostics #Breastcancer
Resitu wins FDA clearance for breast biopsy device
Swedish MedTech firm has received US FDA 510(k) clearance for a handheld, single-use device designed for minimally invasive biopsy.
druganddeviceworld.com
October 2, 2025 at 4:26 PM
phalguniddw.bsky.social
Resitu Medical's breast biopsy device, RESL09, receives US FDA 510(k) clearance. This minimally invasive tool for large tissue samples is a breakthrough for cancer diagnostics.

#News #BreastBiopsy #FDA #MedTech #Innovation #CancerDiagnostics #Diagnostics #Breastcancer
Resitu wins FDA clearance for breast biopsy device
Swedish MedTech firm has received US FDA 510(k) clearance for a handheld, single-use device designed for minimally invasive biopsy.
druganddeviceworld.com
October 2, 2025 at 4:26 PM
oncoassist.bsky.social
#ONCOnews #OncoAlert #OncEd #FDAApproval #CancerDiagnostics #AcuteLeukemia
September 23, 2025 at 10:30 AM
potsdamsciencepark.bsky.social
📣 REMINDER to Lunch & Learn with Dr. Hans-Jörg Warnatz on »𝗔𝗻𝘁𝗶𝗯𝗼𝗱𝗶𝗲𝘀 𝗳𝗼𝗿 𝗖𝗮𝗻𝗰𝗲𝗿 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀 𝗔𝗿𝗼𝘂𝗻𝗱 𝘁𝗵𝗲 𝗪𝗼𝗿𝗹𝗱 𝗠𝗮𝗱𝗲 𝗶𝗻 𝗕𝗿𝗮𝗻𝗱𝗲𝗻𝗯𝘂𝗿𝗴« | Sept. 23 | 12-13 h.

🖍️ Register via: potsdam-sciencepark.de/en/events/

#biocyc #monoclonalantibodies #pathology #cancerdiagnostics
September 17, 2025 at 8:37 AM
d-and-d-world.bsky.social
Stratipath and PathAI join forces to expand global access to AI-powered breast cancer diagnostics through AISight Dx. Faster, scalable, and more equitable care.
#News #AI #CancerDiagnostics #BreastCancer #DigitalPathology #HealthcareInnovation
Stratipath and PathAI partner to advance AI cancer diagnostics
Partnership integrates Stratipath Breast into PathAI’s AISight Dx, expanding global access to rapid AI-based cancer diagnostics.
druganddeviceworld.com
September 4, 2025 at 7:38 PM
phalguniddw.bsky.social
Stratipath and PathAI join forces to expand global access to AI-powered breast cancer diagnostics through AISight Dx. Faster, scalable, and more equitable care.
#News #AI #CancerDiagnostics #BreastCancer #DigitalPathology #HealthcareInnovation
Stratipath and PathAI partner to advance AI cancer diagnostics
Partnership integrates Stratipath Breast into PathAI’s AISight Dx, expanding global access to rapid AI-based cancer diagnostics.
druganddeviceworld.com
September 4, 2025 at 7:38 PM
oncoassist.bsky.social
🚨New in #Oncology!

✅ Agilent’s MMR IHC Panel pharmDx(Dako Omnis) receives European IVDR Certification

🌍 Approved as a Companion Diagnostic for Colorectal Cancer — advancing precision oncology across Europe

🔗 bit.ly/ONCOnews3S-1

#ONCOnews #OncoAlert #OncEd #CancerDiagnostics #ColorectalCancer
September 3, 2025 at 1:01 PM
jsantoyo.bsky.social
Deep learning–driven multi-omics analysis: enhancing cancer diagnostics and therapeutics. #DeepLearning #MultiOmics #CancerDiagnostics #BriefingsInBioinformatics
academic.oup.com/bib/article/...
August 31, 2025 at 3:01 PM
cizzlebio.com
#CizzleBio #AABIP2025 #EarlyDetection #Pulmonology #CancerDiagnostics #BiotechInnovation
August 8, 2025 at 8:43 PM
healthdivine.bsky.social
🧪 Minimal Residual Disease Testing Market is booming—expected to hit $84.2B by 2032 with a whopping 12.55% CAGR 🔬

#CancerDiagnostics #MRDTesting #OncologyInnovation

industrytoday.co.uk/health_and_s...
Minimal Residual Disease Testing Market Projected to Hit USD 8.42 Billion by 2032, at a Exceptional CAGR 12.55% - Industry Today
Minimal Residual Disease Testing Market CAGR is expected to be around 12.55% during the forecast period 2025 - 2032
industrytoday.co.uk
August 7, 2025 at 12:36 PM
newsramp.com
Pearsanta receives DoD invitation for groundbreaking ovarian cancer diagnostic research, potentially revolutionizing early detection methods with innovative blood-based test #MedicalResearch #CancerDiagnostics
Image from article
July 24, 2025 at 4:36 PM
healthdivine.bsky.social
🔬 Clarity saves lives! Japan’s #PathologicalMicroscopes market supports next-gen cancer, cell & tissue diagnostics.
#LabTech #MedicalMicroscopes #PathologyJapan #CancerDiagnostics #PrecisionLab

www.marketresearchfuture.com/reports/japa...
Japan Pathological Microscopes Market Size, Growth Report 2035
Japan Pathological Microscopes Market Industry is expected to grow from 6.5(USD Million) in 2025 to 12.9 (USD Million) by 2035. The Japan Pathological Microscopes Market CAGR (growth rate) is expected...
www.marketresearchfuture.com
July 24, 2025 at 3:42 PM
healthdivine.bsky.social
Cancer detection gets smarter! 🧪🔍 France leads the way in liquid biopsy.
#CancerDiagnostics #LiquidBiopsy #InnovationFrance 🇫🇷🧬

www.marketresearchfuture.com/reports/fran...
France Liquid Biopsy Market Size, Growth Outlook 2035
France Liquid Biopsy Market growth is projected to reach USD 1027.56 Billion, at a 10.541% CAGR by driving industry size, share, top company analysis, segments research, trends and forecast report 202...
www.marketresearchfuture.com
July 22, 2025 at 4:54 PM
flomics.bsky.social
Together, step by step, we’re making great strides — the best is yet to come!🚀💪

#LiquidBiopsy #CfRNA #RNASeq #Transcriptomics #Biomarkers #Bioinformatics #PrecisionMedicine #Preprint #CancerDiagnostics #Flomics #MethodsMatter #Reproducibility #Genomics #Diagnostics
July 15, 2025 at 8:56 AM
hmbcsantos.bsky.social
Huge credit to André Figueiredo (PhD, Biochem
@laqv-requimte.bsky.social). Collaboration with @UPMC
fueling clinical impact.

📎 Full story: doi.org/10.1016/j.ta...
#Proteomics #ccRCC #pRCC #chRCC #Oncocytoma #CancerDiagnostics #PROTEOMICSNOVA
July 12, 2025 at 10:50 AM
gauravpatilll.bsky.social
Advance cancer care with Solid Tumor Testing 🔬🎯. Explore cutting-edge diagnostics, market trends, and growth insights driving precision oncology worldwide. #SolidTumorTesting #CancerDiagnostics #OncologyMarket #PrecisionMedicine #HealthcareTech 🧬📊
www.statsandresearch.com
July 11, 2025 at 12:07 PM
flo7up.bsky.social
Lunit uses Microsoft Azure's AI and cloud to enable customizable cancer diagnostics and workflow automation in radiology, improving global healthcare access and care consistency. #healthtech #AI #cloud #cancerdiagnostics
Lunit Partners with Microsoft to Scale AI-Powered Cancer Diagnostics Globally
Lunit Partners with Microsoft to Scale AI-Powered Cancer Diagnostics Globally
biopharmaapac.com
July 4, 2025 at 7:02 PM